ReviewTherapeutic advances in drug safety2015

Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function.

Raquel Esteras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.